Enabling the potential of automation
When two architects from Zaha Hadid’s research lab first approached robotics, their idea was to explore applications specific to architectural engineering.
But they soon discovered that modern automation wasn’t just unnecessarily complex – it was actively restricting innovation. And not just within their industry – in many others too. It was clear that robotic automation was a field where their combined experience in computational research and design could make a real difference.
Assembling a team of industry experts, Automata was founded with a clear aim: to enable new opportunities for innovation with automation.
Unlocking the potential of labs
Automata’s focus narrowed on an industry where they felt their expertise could have the most impact: the life sciences.
Today, most lab automation tends to be defined by a series of very specialised benchtop instruments that are still reliant on human interaction. But Automata saw an opportunity for a new way of looking at automation in the life sciences: open, integrated automation.
That’s how we came to develop the world’s first fully automated lab bench, and its accompanying software. This enables labs to use staff and resources more effectively by ensuring total walkaway time and consistency, without compromising on valuable lab space
The leadership team
Thank you, EVA
EVA was the brainchild of former architects Mostafa ElSayed and Suryansh Chandra when, back in 2015, they founded Automata with the vision of making automation more accessible. With this mission, they assembled a team of industry experts, and EVA was born.
We’ve come a long way since then. And although we stopped producing EVA’s in 2022, we will always be indebted to – and thankful for – our history as the manufacturer of EVA.
In fact, many of the principles we established back at the company’s beginnings remain a huge part of who we are today; our approach to doing robotics differently, our passion for transforming industries with automation; and, of course, our team of amazing minds that are still creating innovative products to this day.
Automata is now proud to deploy our flagship product, LINQ, a lab automation platform enabling life science labs to fully automate their workflows.
Press
Automata secures $40m fundraise backed by Dimension and A.P. Moller Holding, to…
Read more Automata raises $40m to accelerate growth and global presenceAutomata partners with The Royal Marsden to increase cancer genomic testing capacity…
Read more Automata partners with The Royal MarsdenAutomata partners with The Francis Crick Institute on integrated automation for genomics…
Read more Automata partners with The Francis Crick Institute